Assessment of neutron/gamma-ray dose ratios in intracavitary 252Cf neutron therapy.
252Cf was used to treat tumors of the cervix, vagina, and uterus. Dosimetric analysis and assessment of n/gamma ratios achievable under clinical conditions indicate that this radionuclide may be useful in gynecologic brachytherapy.
D000230:Adenocarcinoma / Q000532:radiotherapy; D002142:Californium / Q000008:administration & dosage / Q000627:therapeutic use*; D002277:Carcinoma / Q000532:radiotherapy; D005260:Female; D006801:Humans; D011879:Radiotherapy Dosage; D014594:Uterine Neoplasms / Q000532:radiotherapy*; D014625:Vaginal Neoplasms / Q000532:radiotherapy*
D002142:Californium